ICoLA 2021

  The International Congress on Lipid and Atherosclerosis (ICoLA) 2021 will be held at Conrad Seoul, Korea on Sep 10-11, 2021 (Hybrid). This meeting will include not only the latest results of research on clinical lipidology and atherosclerotic cardiovascular disease, but also those on basic sciences, genetic/ epigenetic studies, and nutritional sciences. In this regard, it will provide chance for participants (cardiologists, endocrinologists, vascular biologists, nutritionists, and much more) with insights into the field of lipid and atherosclerosis.

  The Scientific Program Committee (chair: Dr Sang-Hak Lee, secretaries: Drs SungWan Chun and Chan Joo Lee), have planned six plenary lectures, 21 symposia, and two joint symposia to promote exchanging knowledge and opinions among field leaders and participants. Plenary lectures include epidemiology, optimal medical therapy for coronary plaque, hypertriglyceridemia, single cell sequencing, genetic/epigenetic approach, and smooth muscle cells in atherosclerosis.

  Symposia are prepared on cutting edge sciences in different sessions. Clinical sessions include: risk assessment, TG metabolism, atherosclerosis imaging, current lipid-lowering therapy, PCSK9 inhibitors and omega-3 PUFA, novel therapeutic agents, studies on platelets, Lp(a) and inflammation, and familial hypercholesterolemia. Basic and translational sessions include: vascular immune cells, role of endothelial cells, influence of metabolic dysfunction, new techniques in atherosclerosis research, lipoprotein metabolism and regulation, studies on high-density lipoprotein, and noncoding RNAs. Nutrition sessions include: Korean Dietary Reference Intakes and lifestyle/nutrition modification.

  We look forward to seeing you in ICoLA 2021.

Program Download

Day 1 (Friday, September 10, 2021)

Floor	3F			5F	6F
Room	Room 1	Room 2	Room 3	Room 4	Room 5
08:00 - 09:00	BREAKFAST SYMPOSIUM 1 [AstraZeneca]	BREAKFAST SYMPOSIUM 2 [Pfizer/BMS]	BREAKFAST SYMPOSIUM 3 [Sanofi]
09:00 - 09:30	PLENARY LECTURE 1 What’s new in epidemiology of atherosclerotic cardiovascular disease and its risk factors Raul D. Santos (University of Sao Paulo, Brazil)
09:30 - 09:40	BREAK
09:40 - 11:15	SYMPOSIUM 1 Emerging risk factors for atherosclerosis	SYMPOSIUM 2 Risk assessment for primary prevention	SYMPOSIUM 3 Clinical implication of genetic/epigenetic studies on coronary artery disease & dyslipidemia	SYMPOSIUM 4 Immune cells in blood vessels	SYMPOSIUM 5 New look at smooth muscle cells in atherosclerosis
11:15 - 11:25	COFFEE BREAK
11:25 - 11:35	OPENING ADDRESS
11:35 - 12:05	PLENARY LECTURE 2 Single cell RNA and antibody sequencing in women and men with cardiovascular disease Klaus Ley (La Jolla Institute for Immunology, USA)
12:05 - 13:05	LUNCHEON SYMPOSIUM 1 [Organon]	LUNCHEON SYMPOSIUM 2 [Amgen]	LUNCHEON SYMPOSIUM 3 [Viatris]	LUNCHEON SYMPOSIUM 4 [Yuhan]
13:05 - 14:05	ORAL PRESENTATION 1	2021 KSoLA AWARDS FOR SCIENTIFIC EXCELLENCE AND YOUNG INVESTIGATOR Scientific Excellence Award Lecture	ORAL PRESENTATION 2
14:05 - 14:35	PLENARY LECTURE 3 Optimal medical therapy to inhibit coronary plaque Ken-ichi Hirata (Kobe University, Japan)
14:35 - 14:45	COFFEE BREAK
14:45 - 16:20	SYMPOSIUM 6 TG metabolism & lipolysis	SYMPOSIUM 7 Imaging of atherosclerosis	SYMPOSIUM 8 Role of endothelial cells & ROS in atherosclerosis	SYMPOSIUM 9 Korean Dietary Reference Intakes(KDRI) for chronic disease risk reduction
16:20 - 16:30	BREAK
16:30 - 18:05	SYMPOSIUM 10 Principles & limitation of current lipid-lowering therapy	SYMPOSIUM 11 (Joint with IAS) Latest trend of lipid modifying strategies	SYMPOSIUM 12 Influence of metabolic dysfunction in atherosclerosis	SYMPOSIUM 13 New techniques in basic atherosclerosis research
18:05 -	DINNER

Day 2 (Saturday, September 11, 2021)

Floor	3F			5F	6F
Room	Room 1	Room 2	Room 3	Room 4	Room 5
08:00 - 09:00	BREAKFAST SYMPOSIUM 4 [Yooyoung]	BREAKFAST SYMPOSIUM 5 [Chong Kun Dang]	BREAKFAST SYMPOSIUM 6 [Celltrion/Jeil Pharmaceutical]		KSoLA Executive Meeting (07:30-08:30)
09:00 - 09:30	PLENARY LECTURE 4 Hypertriglyceridemia: diagnostic and therapeutic implications Alan Remaley (National Institutes of Health, USA)
09:30 - 09:40	BREAK
09:40 - 11:20	SYMPOSIUM 14 Recent studies on PCSK9 inhibitors & omega-3 PUFA	SYMPOSIUM 15 New treatment agents for dyslipidemia	SYMPOSIUM 16 Update on lipoprotein metabolism & regulation	SYMPOSIUM 17 What’s new in lifestyle/nutrition modification	SYMPOSIUM 18 (Joint with JAS) Update on platelet in atherosclerosis & acute coronary syndrome
11:20 - 11:40	COFFEE BREAK
11:40 - 12:10	PLENARY LECTURE 5 Genetics/epigenetic approach in studies of lipid metabolism & atherosclerosis Kiran Musunuru (University of Pennsylvania, USA)
12:10 - 13:10	LUNCHEON SYMPOSIUM 5 [Daewoong]	LUNCHEON SYMPOSIUM 6 [JW Pharmaceutical]	LUNCHEON SYMPOSIUM 7 [Hanmi]	LUNCHEON SYMPOSIUM 8 [HK. inno.N]
13:10 - 14:10	ORAL PRESENTATION 3		ORAL PRESENTATION 4
14:10 - 14:40	PLENARY LECTURE 6 Targeting smooth muscle cell in management of atherosclerotic cardiovascular disease Martin Bennett (University of Cambridge, UK)
14:40 - 15:00	COFFEE BREAK
15:00 - 16:40	SYMPOSIUM 19 Targeting Lp(a) & inflammation in ASCVD	SYMPOSIUM 20 Current & future treatment for HeFH & HoFH	SYMPOSIUM 21 HDL update	SYMPOSIUM 22 Role of noncoding RNA in lipid metabolism & vascular disease	PUBLICATION COMMITTEE SESSION
16:40 - 16:50	BREAK
16:50 -	CLOSING CEREMONY

Program at a glance

Day 1 (Friday, September 10, 2021)

Day 2 (Saturday, September 11, 2021)